Marta Sonia G. P.
- Country
- Spain
- Department
- Servicio de Hematologia
Research Overview
- Evaluation of Humanized CAR T-Cell Therapy ARI0002h Targeting BCMA in Patients with Relapsed/Refractory Multiple Myeloma Resistant to Proteasome Inhibitors, Immunomodulators, and Anti-CD38 Antibody
- Efficacy and Safety of Etentamig and Daratumumab Versus Daratumumab and Combination Therapy in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma
- Phase 3 Randomized Study of JNJ‑79635322 Versus Teclistamab in Relapsed or Refractory Multiple Myeloma After 1–3 Prior Lines Including Anti‑CD38 Antibody and Lenalidomide
Data & Insights
Has run more than one trial at 189 of 335 partner sites.
Specializations
Cardiovascular Medicine
Clinical research activity includes atherosclerotic cardiovascular disease, acute myocardial infarction, heart failure, atrial fibrillation, hypertension, dyslipidemia, and transthyretin amyloid cardiomyopathy, with additional interest in stroke prevention and inherited cardiomyopathy risk.
- Coronary artery disease
- Heart failure with reduced ejection fraction
- Ischemic stroke prevention
- Familial hypercholesterolemia
The therapeutic focus also extends to cardiometabolic risk reduction, cardiac amyloidosis, and antithrombotic strategies.
Oncology and Hematologic Malignancies
The investigator is involved in trials across breast cancer, non-small cell lung cancer, ovarian cancer, prostate cancer, urothelial carcinoma, multiple myeloma, and lymphoma, including advanced and metastatic disease settings.
- HER2-negative and HER2-positive breast cancer
- Multiple myeloma
- Metastatic non-small cell lung cancer
- Lymphoid malignancies
Research interests include targeted therapies, immunotherapy, antibody-drug conjugates, and precision approaches in molecularly defined tumors.
Autoimmune, Inflammatory, and Rheumatologic Diseases
Clinical trial involvement covers rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, systemic lupus erythematosus, systemic sclerosis, Crohn’s disease, and ulcerative colitis, with activity across both systemic and organ-specific immune-mediated disorders.
- Psoriasis
- Inflammatory bowel disease
- Connective tissue disease
- Myasthenia gravis
The therapeutic landscape also includes biologic therapy, immune modulation, and treatment of refractory inflammatory disease.
Respiratory and Allergic Disorders
Research interests include asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, bronchiectasis, and respiratory syncytial virus prevention, alongside allergic and eosinophilic disease.
- Severe eosinophilic asthma
- Interstitial lung disease
- Chronic rhinosinusitis with nasal polyps
- Respiratory infection prevention
Therapeutic activity also reflects interest in anti-inflammatory respiratory treatments and progressive fibrotic lung disease.
Metabolic, Renal, and Rare Diseases
The investigator participates in studies of IgA nephropathy, lupus nephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, metabolic dysfunction-associated steatohepatitis, and inherited metabolic conditions.
- Kidney disease
- Liver fibrosis
- Complement-mediated disorders
- Inborn errors of metabolism
Additional areas include thyroid eye disease, growth disorders, and other uncommon pediatric and adult conditions with unmet therapeutic need.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.